Page last updated: 2024-08-23

n-nitrosoiminodiacetic acid and Opioid-Related Disorders

n-nitrosoiminodiacetic acid has been researched along with Opioid-Related Disorders in 5 studies

*Opioid-Related Disorders: Disorders related to or resulting from abuse or misuse of OPIOIDS. [MeSH]

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's4 (80.00)2.80

Authors

AuthorsStudies
Botbyl, JD; Campbell, ANC; Luderer, HF; Maricich, YA; Nunes, EV1
Kropp, FB; Lofwall, MR; Martin, PR; Murphy, SM; Smid, MC; Wachman, EM; Wilder, CM; Winhusen, TJ1
Aalsma, M; Ahrens, K; Blackburn, N; Haggerty, K; Joseph, E; Kelleher, K; Knight, DK; Mulford, C; Ryle, T; Tolou-Shams, M1
Costello, E; Novo, P; Nunes, EV; Rotrosen, J; Shulman, M; Weiss, R1
Houck, LK; Katz, N; Kleber, HD; Sabo, A; Smith, MY1

Reviews

1 review(s) available for n-nitrosoiminodiacetic acid and Opioid-Related Disorders

ArticleYear
Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)".
    Addiction science & clinical practice, 2021, 03-06, Volume: 16, Issue:1

    Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Humans; Naltrexone; Narcotic Antagonists; Nitrosamines; Opiate Substitution Treatment; Opioid-Related Disorders; United States

2021

Trials

2 trial(s) available for n-nitrosoiminodiacetic acid and Opioid-Related Disorders

ArticleYear
Safety and efficacy of a digital therapeutic for substance use disorder: Secondary analysis of data from a NIDA clinical trials network study.
    Substance abuse, 2022, Volume: 43, Issue:1

    Topics: Buprenorphine; Central Nervous System Stimulants; Cocaine; Humans; Nitrosamines; Opiate Substitution Treatment; Opioid-Related Disorders; Substance-Related Disorders

2022
Collaborative care programs for pregnant and postpartum individuals with opioid use disorder: Organizational characteristics of sites participating in the NIDA CTN0080 MOMs study.
    Journal of substance use and addiction treatment, 2023, Volume: 149

    Topics: Buprenorphine; Female; Humans; Mothers; Opiate Substitution Treatment; Opioid-Related Disorders; Postpartum Period; Pregnancy

2023

Other Studies

2 other study(ies) available for n-nitrosoiminodiacetic acid and Opioid-Related Disorders

ArticleYear
Prevention of Opioid Use and Disorder Among Youth Involved in the Legal System: Innovation and Implementation of Four Studies Funded by the NIDA HEAL Initiative.
    Prevention science : the official journal of the Society for Prevention Research, 2023, Volume: 24, Issue:Suppl 1

    Topics: Adolescent; Analgesics, Opioid; Drug Overdose; Humans; Opioid-Related Disorders; Social Problems

2023
Reducing opioid. analgesic abuse: models for successful collaboration among government, industry and other key stakeholders.
    Drug and alcohol dependence, 2008, May-01, Volume: 95, Issue:1-2

    Topics: Analgesics, Opioid; Cooperative Behavior; Drug and Narcotic Control; Drug Industry; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Humans; Nitrosamines; Opioid-Related Disorders; Pain; Risk Management; United States; United States Food and Drug Administration

2008